FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ACLIMOSTAT
异名/同义词(3R,4S,5S,6R)5METHOXY4((2R,3R)2METHYL3(3METHYLBUT2EN1YL)OXIRAN2YL)1OXASPIRO(2.5)OCTAN6YL 3(2(MORPHOLIN4YL)ETHYL)AZETIDINE1CARBOXYLATE
(3R,4S,5S,6R)-5-METHOXY-4-((2R,3R)-2-METHYL-3-(3-METHYLBUT-2-EN-1-YL)OXIRAN-2-YL)-1-OXASPIRO(2.5)OCTAN-6-YL 3-(2-(MORPHOLIN-4-YL)ETHYL)AZETIDINE-1-CARBOXYLATE
1-AZETIDINECARBOXYLIC ACID, 3-(2-(4-MORPHOLINYL)ETHYL)-, (3R,4S,5S,6R)-5-METHOXY-4-((2R,3R)-2-METHYL-3-(3-METHYL-2-BUTEN-1-YL)-2-OXIRANYL)-1-OXASPIRO(2.5)OCT-6-YL ESTER
ACLIMOSTAT
ACLIMOSTAT [INN]
ACLIMOSTAT [WHO-DD]
ZGN-1061
CAS登记号2082752-83-6
物质唯一标识(Unique Ingredient Identifier)X150A3JK8R
分子式C26H42N2O6
国际化合物标识(International Chemical Identifier,InChI)QJWJPMLDQYEPPW-AUKZVGPFSA-N
SMILESO([C@@H]1CC[C@@]2([C@@]([C@]3(C)[C@@H](CC=C(C)C)O3)([C@@H]1OC)[H])CO2)C(N4CC(CCN5CCOCC5)C4)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System